Emerging Trends and Opportunities in the Antimicrobial Susceptibility Testing Market

Meticulous Research®, the antimicrobial susceptibility testing (AST) market is projected to reach $7.21 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% over the forecast period. The primary factors driving this market's growth include an increasing risk of infectious diseases, a rise in infections caused by antimicrobial-resistant pathogens, and growing global concerns about antimicrobial resistance (AMR).

Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5062

In addition, supportive initiatives and funding for AMR research, alongside active R&D efforts to develop rapid AST solutions and growth opportunities in emerging markets, are also contributing to market expansion.

Key Market Players
The report profiles several key players in the antimicrobial susceptibility testing market, including Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).

Browse in depth: https://www.meticulousresearch.com/product/antimicrobial-susceptibility-testing-market-5062

Market Segmentation
The global antimicrobial susceptibility testing market is segmented by product (Manual AST Products, Consumables, Automated AST Products), method (Disk Diffusion, Automated AST, Dilution, Other Methods), test type (Antibacterial, Anti-parasitic, Antifungal, Other Test Types), application (Clinical Diagnostics, Drug Discovery & Development, Other Applications), and end user (Diagnostic Laboratories & Hospitals, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes). The study also provides an in-depth competitive analysis, including global and regional market shares.

In 2024, the manual antimicrobial susceptibility testing products segment is expected to hold the largest market share. The dominance of this segment is mainly due to the low cost and ease of use of manual AST products. Additionally, the availability of various consumables for manual testing and the simplicity of test interpretation are contributing to its growth.

Among the different methods, the disk diffusion method is anticipated to account for the largest market share in 2024. The cost-effectiveness of the disk diffusion method, combined with recent advancements in technology, supports this method's dominance. Known as the Kirby-Bauer method, disk diffusion is widely used in clinical settings due to its simplicity, flexibility, and ability to deliver qualitative, interpretative results. It can be performed with minimal equipment, such as Mueller-Hinton agar, calipers, rulers, and incubators, making it the most affordable susceptibility testing method available.

Click here for top 10 blog: https://meticulousblog.org/top-10-companies-in-antimicrobial-susceptibility-testing-market/

Leading Test Types and Applications
In 2024, antibacterial tests are expected to dominate the market in terms of test type. This is driven by their high usage in clinical diagnosis, the increasing prevalence of bacterial infections, the emergence of antibiotic-resistant bacteria, and their cost-effectiveness, speed, and ease of use.

For applications, the clinical diagnostics segment is expected to hold the largest share of the market in 2024, due to the growing burden of antimicrobial resistance and increased awareness of AST methods.

Key End Users
Among end users, diagnostic laboratories and hospitals are projected to hold the largest market share in 2024. This is attributed to the availability of advanced facilities, trained technicians, the rising incidence of hospital-acquired infections, and strategic initiatives by key market players to provide AST products through these channels.

Geographic Insights
This report offers a comprehensive analysis of major geographic regions, including North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to dominate the AST market in 2024, followed by Europe and Asia-Pacific.

Quick buy: https://www.meticulousresearch.com/Checkout/47104827

Key drivers in North America include the adoption of advanced susceptibility testing technologies, ongoing research for new drugs using ASTs, and heightened awareness of treatment options. Favorable government initiatives also support market growth. For example, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) 2020-2025, launched in October 2020, aims to enhance health and well-being by addressing antibiotic resistance through strategic, coordinated actions.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.